Shang Hai Zheng Quan Bao·2025-12-22 17:58Core Viewpoint - Rongchang Biopharmaceutical (Yantai) Co., Ltd. plans to repurchase shares through centralized bidding, with a total repurchase amount between RMB 20 million and RMB 40 million, aimed at employee stock ownership plans or equity incentives [1][6]. Group 1: Repurchase Plan Details - The repurchase will utilize the company's own funds and/or self-raised funds [1][12]. - The maximum repurchase price is set at RMB 95 per share, which does not exceed 150% of the average trading price over the last 30 trading days prior to the board's decision [1][11]. - The repurchase period is set for 12 months from the date of board approval [3][8]. Group 2: Purpose and Impact - The purpose of the repurchase is to enhance employee motivation, establish a long-term incentive mechanism, and boost investor confidence [6][13]. - The repurchased shares will be used for employee stock ownership plans or equity incentives, and any unused shares after three years will be canceled [1][12]. - The financial impact of the repurchase is minimal, with the maximum repurchase amount representing only 0.67% of total assets and 1.72% of net assets as of September 30, 2025 [12][13]. Group 3: Shareholder and Management Plans - As of the announcement date, major shareholders and management have no plans to reduce their holdings in the next three to six months [3][14]. - The board has authorized management to handle all matters related to the share repurchase, including timing, price, and quantity adjustments as necessary [15][16].